Target intelligence / Profile preview

Pathogenesis-related protein PR-10.01 (Ara h 8) (Ara h 8)

Target
Ara h 8
Molecular classification
Pathogenesis-related protein family 10 (PR-10), Bet v 1 family
01

Overview

Ara h 8 is a 17 kDa protein from the peanut (Arachis hypogaea) belonging to the pathogenesis-related protein family 10 (PR-10). It is a structural homolog of the major birch pollen allergen Bet v 1 and is primarily associated with Oral Allergy Syndrome (OAS) or Pollen-Food Allergy Syndrome (PFAS) in individuals sensitized to birch pollen. Unlike the major peanut storage proteins such as Ara h 1, 2, 3, and 6, Ara h 8 is heat-labile and sensitive to proteolytic digestion, which typically results in milder, localized symptoms like itching of the mouth and throat rather than systemic anaphylaxis. In clinical diagnostics, the presence of Ara h 8-specific IgE in the absence of IgE against storage proteins often indicates a low risk for severe peanut allergy and suggests cross-reactivity with tree pollens. While not a traditional therapeutic target for small molecules or biologics, Ara h 8 is a critical component in molecular allergy diagnostics and is present in allergen extracts used for immunotherapy. Its biological function in the peanut plant involves defense against pathogens and the binding of hydrophobic ligands such as flavonoids like quercetin and apigenin. The protein's structure consists of a seven-stranded antiparallel beta-sheet and three alpha-helices, forming a large internal cavity for ligand binding. Understanding Ara h 8 sensitization is essential for distinguishing between primary peanut allergy and secondary cross-reactivity, which informs patient management and risk assessment.

Other names
Ara h 8.0101Ara h 8.0201Bet v 1-homologous allergenPR-10 proteinPeanut allergen Ara h 8
02

Mechanism of action

Allergen immunotherapy (desensitization)

03

Biological functions

Plant defenseLigand bindingFlavonoid transport
04

Disease associations

Peanut allergyOral Allergy SyndromePollen-Food Allergy Syndrome
05

Safety considerations

Risk of anaphylaxis during diagnostic challengesCross-reactivity with birch pollen allergensHeat and digestion lability
06

Interacting drugs

Peanut allergen powder
07

Biomarkers

Ara h 8-specific IgE (sIgE)

Beyond the preview

Go deeper on Pathogenesis-related protein PR-10.01 (Ara h 8) (Ara h 8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenesis-related protein PR-10.01 (Ara h 8) (Ara h 8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call